pharmaceutical interventions

This week I am talking to Micha Breakstone, (@michabreakstone) CEO and Co-FOunder of Neuralight.ai (@neuralight) a company using novel objective and sensitive neurological biomarkers to accelerate neurological trials and increase their success rates Micah has an unusual background and history who thought he would be a novelist but found his way into serial entrepreneurship successfully launching […]

Read

This week I am talking to Doug Miller, PhD, Chief Technology Officer for SmartTab (@veloce_smarttab) a company developing an advanced platform of ingestible capsules for oral drug delivery of biologics and targeted medications. Doug started out in avionics but quickly found himself in the world of healthcare focused on drugs and drug delivery mechanisms. At SmartTab they […]

Read

The latest data is creating additional concerns with the rising incidence of the Delta variant that is running through communities, especially those that are unvaccinated. There are a number of factors at play with increased transmissibility that appears to be attributable to the virus shedding in infected individuals earlier and at high rates (Viral infection […]

Read

This week Fred and I dive into SARS-CoV-2 variants, what they are, what they mean and how they work. We discuss why some of these variants appear to be more infectious and review the ongoing stream of news around variants and how you should interpret this news and its impact on your businesses, employees, students […]

Read

This week’s discussion centers on the latest trend of “Vaccine Shopping”. What’s that you ask – I had the same question. For some who are struggling with accessing appointments, worried that their appointment might be canceled, or even thinking they want to pick and choose the vaccine they get, they are booking multiple appointments. While […]

Read



Search